Lucas Ward
Stock Analyst at Ascendiant Capital
(0.33)
# 4,420
Out of 5,172 analysts
27
Total ratings
18.52%
Success rate
-40.76%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIQT LiqTech International | Maintains: Buy | $4.2 → $4.3 | $1.59 | +170.44% | 7 | Mar 10, 2026 | |
| HSCS HeartSciences | Maintains: Buy | $9 → $9.2 | $2.55 | +260.78% | 4 | Dec 22, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.5 → $5.5 | $1.22 | +350.82% | 5 | Dec 3, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $12 → $11 | $1.95 | +474.36% | 4 | Nov 28, 2025 | |
| ACON Aclarion | Maintains: Buy | $22 → $23 | $3.20 | +618.75% | 5 | Nov 20, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $135,000 → $108,000 | $2.09 | +5,167,364.11% | 2 | Jul 29, 2024 |
LiqTech International
Mar 10, 2026
Maintains: Buy
Price Target: $4.2 → $4.3
Current: $1.59
Upside: +170.44%
HeartSciences
Dec 22, 2025
Maintains: Buy
Price Target: $9 → $9.2
Current: $2.55
Upside: +260.78%
Vivos Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $6.5 → $5.5
Current: $1.22
Upside: +350.82%
60 Degrees Pharmaceuticals
Nov 28, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $1.95
Upside: +474.36%
Aclarion
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $3.20
Upside: +618.75%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $135,000 → $108,000
Current: $2.09
Upside: +5,167,364.11%